🔬Deep Research

PGNY — Progyny · catalysts, narrative & risks

·26 sourcesPGNY forecast →

Snapshot

Progyny, Inc. (Nasdaq: PGNY) is a New York–based employer-sponsored fertility, family-building, and women's-health benefits manager that completed its Nasdaq IPO in 2019 [1][21]. It is classified within the digital-health space in our coverage universe [1]. As of the Nov 13, 2026 close, the stock last traded at $36.18, down 1.09% on the day [8], and has been cited near a $2.6B market capitalization [13]. The stock's sensitivity to news flow is consistent with the research library's observation that financial-news sentiment and price discovery interact closely in equity moves [LIB-1][LIB-2].

Recent catalysts (last ~1–3 months)


AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →